# US 2004/0079671 A1 · Medicinal product packaging

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0079671 A1
- Document ID: US20040079671A1
- Status: Published application
- Kind: A1
- Application number: 10/649,300
- Filed: 2003-08-27
- Published: 2004-04-29
- Earliest claimed: 2002-08-29
- Inventors: Paramita Bandyopadhyay; David S. Baker; Carolyn V. Pesheck; Brian E. Thompson
- Web page: https://patentgrep.com/patent/US20040079671A1

## CPC

- A61K 31/557: Eicosanoids, e.g. leukotrienes {or prostaglandins}
- A61P 27/02: Ophthalmic agents
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A packaged medicinal product comprising a medicinal preparation packaged in a plastic container having a fluorinated barrier layer on a surface of its body wall is disclosed. The fluorinated barrier layer on the surface of container body wall reduces the loss of an ingredient in the medicinal preparation through the container body wall, and reduces the transfer of impurities into the medicinal preparation from the container materials, from label-related materials, or from the environment where the packaged medicinal preparation is stored.

## Claims

### Claim 1

A packaged medicinal product having extended shelf-life comprising:
(a) a medicinal preparation; and
(b) a plastic container having a fluorinated barrier layer on a surface of the body wall,
wherein the body of the container is fill with the medicinal preparation.

### Claim 2 (depends on 1)

A packaged medicinal product according to claim 1, wherein the medicinal preparation is a liquid.

### Claim 3 (depends on 2)

A packaged medicinal product according to claim 2, wherein the medicinal preparation comprises a highly potent ingredient.

### Claim 4 (depends on 3)

A packaged medicinal product according to claim 3, wherein the highly potent ingredient is a prostaglandin.

### Claim 5 (depends on 1)

A packaged medicinal product according to claim 1, wherein the container is made of materials comprising LDPE, HDPE or PP.

### Claim 6 (depends on 5)

A packaged medicinal product according to claim 5, wherein the container is a small volume bottle.

### Claim 7 (depends on 6)

A packaged medicinal product according to claim 6, wherein the medicinal preparation comprises a prostaglandin.

### Claim 8 (depends on 7)

A packaged medicinal product according to claim 7, which is for ophthalmic use.

### Claim 9

A method of packaging a medicinal preparation, said method comprising the steps of:
(a) providing a plastic container having a fluorinated barrier layer on a surface of its body wall; and
(b) filling the container body with the medicinal preparation.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the medicinal preparation is a liquid.

### Claim 11 (depends on 10)

The method according to claim 10, wherein the medicinal preparation comprises a highly potent ingredient.

### Claim 12 (depends on 11)

The method according to claim 11, wherein the highly potent ingredient is a prostaglandin.

### Claim 13 (depends on 9)

The method according to claim 9, wherein the container is made of materials comprising LDPE, PP, HDPE.

### Claim 14 (depends on 13)

The method according to claim 13, wherein the container is a small volume bottle.

### Claim 15 (depends on 14)

The method according to claim 14, wherein the medicinal preparation comprises a prostaglandin.

### Claim 16 (depends on 15)

The method according to claim 15, wherein the medicinal preparation is for ophthalmic use.

### Claim 17

A method of increasing the stability of a liquid medicinal preparation, said method comprising packaging the liquid medicinal preparation in a plastic container having a fluorinated barrier layer on a surface of the container body wall.

### Claim 18 (depends on 17)

The method according to claim 17, wherein the plastic container is made of materials comprising LDPE, PP, HDPE.

### Claim 19 (depends on 18)

The method according to claim 18, wherein the liquid medicinal preparation comprises a highly potent ingredient.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the highly potent ingredient is a prostaglandin.

### Claim 21 (depends on 20)

The method according to claim 20, wherein the medicinal preparation is for ophthalmic use.

### Claim 22

A method of preventing loss of an ingredient in a liquid medicinal preparation through the wall of a plastic container which contains the medicinal preparations, said method comprising packaging the medicinal preparation in the plastic container said container having has a fluorinated barrier layer on a surface of the container body wall.

### Claim 23 (depends on 22)

The method according to claim 22, wherein the plastic container is made of materials comprising LDPE, PP, HDPE.

### Claim 24 (depends on 22)

The method according to claim 22, wherein the liquid medicinal preparation comprises a highly potent ingredient.

### Claim 25 (depends on 24)

The method according to claim 24, wherein the highly potent ingredient is a prostaglandin.

### Claim 26 (depends on 25)

The method according to claim 25, wherein the medicinal preparation is for ophthalmic use.

### Claim 27 (depends on 22)

The method according to claim 22, wherein the container has a fluorinated barrier layer on the inside surface of the container body wall.

### Claim 28

A method of reducing transfer of an impurity into a liquid medicinal preparation upon storage, comprising packaging the liquid medicinal preparation in a plastic container said container having a fluorinated barrier layer on a surface of the container body wall.

### Claim 29 (depends on 28)

The method according to claim 28, wherein the plastic container is made of materials comprising LDPE, PP, HDPE.

### Claim 30 (depends on 28)

The method according to claim 28, wherein the liquid medicinal preparation comprises a highly potent ingredient.

### Claim 31 (depends on 30)

The method according to claim 30, wherein the highly potent ingredient is a prostaglandin.

### Claim 32 (depends on 31)

The method according to claim 31, wherein the medicinal preparation is for ophthalmic use.

### Claim 33 (depends on 28)

The method according to claim 28, wherein the container has a fluorinated barrier layer on the inside surface of the container body wall.
